Thema
Journal Article
46
Randomized Controlled Trial
30
Research Support, Non-U.S. Gov't
28
Antibodies, Monoclonal, Humanized
21
COVID-19
12
Clinical Trial, Phase III
12
Clinical Trial, Phase II
11
Multicenter Study
11
casirivimab and imdevimab drug combination
8
Antibodies, Monoclonal
7
Antibodies, Neutralizing
7
2Z3DQD2JHM
6
AMG 386
6
Clinical Trial, Phase I
6
Drug Combinations
6
J0FI6WE1QN
6
Paclitaxel
6
Pharmacokinetics
6
casirivimab
6
imdevimab
6
420K487FSG
5
6QVL057INT
5
Casirivimab
5
Imdevimab
5
Research Support, N.I.H., Extramural
5
cemiplimab
5
dupilumab
5
monoclonal antibodies
5
570
4
Biology
4
Monoclonal antibodies
4
Recombinant Fusion Proteins
4
Treatment
4
hospitalized
4
615
3
A375 melanoma
3
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
3
Angiogenesis
3
Angiopoietin 1/2-neutralizing peptibody
3
Anti-Asthmatic Agents
3
Antibodies, Viral
3
Antineoplastic Agents
3
Antineoplastic Agents, Immunological
3
CXCR3
3
Clinical trial, phase 1
3
Endothelium
3
Exposure–response analysis
3
G01N: Investigating or analysing materials by determining their chemical or physical properties (measuring or testing processes other than immunoassay, involving enzymes or microorganisms c12m, c12q)
3
Interferon γ–inducible protein 10
3
Ovarian cancer
3
mehr ...